NO326072B1 - Myseprotein-hydrolysat, fremgangsmate for dets fremstilling, farmasoytisk sammensetning, matprodukt samt anvendelse. - Google Patents

Myseprotein-hydrolysat, fremgangsmate for dets fremstilling, farmasoytisk sammensetning, matprodukt samt anvendelse. Download PDF

Info

Publication number: NO326072B1
Authority: NO; Norway
Prior art keywords: seq; approx; hydrolysis; hydrolyzate; enzyme
Prior art date: 2000-09-11

Application number

NO20031096A

Other languages

English (en)

Norwegian (no)

Other versions

NO20031096L (no

NO20031096D0 (no

Inventor

Ralf-Christian Schlothauer

Linda May Schollum

Julian Robert Reid

Stephanie Adele Harvey

Alistair Carr

Rachel Lois Fanshawe

Original Assignee

New Zealand Dairy Board

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-09-11

Filing date

2003-03-10

Publication date

2008-09-15

2003-03-10 Application filed by New Zealand Dairy Board filed Critical New Zealand Dairy Board

2003-03-10 Publication of NO20031096D0 publication Critical patent/NO20031096D0/no

2003-05-07 Publication of NO20031096L publication Critical patent/NO20031096L/no

2008-09-15 Publication of NO326072B1 publication Critical patent/NO326072B1/no

Links

238000000034 method Methods 0.000 title claims abstract description 53
108010046377 Whey Proteins Proteins 0.000 title claims abstract description 52
235000021119 whey protein Nutrition 0.000 title claims abstract description 44
102000007544 Whey Proteins Human genes 0.000 title claims abstract description 43
230000008569 process Effects 0.000 title claims abstract description 20
239000003531 protein hydrolysate Substances 0.000 title claims abstract description 20
235000013305 food Nutrition 0.000 title claims description 10
239000008194 pharmaceutical composition Substances 0.000 title claims description 7
239000000758 substrate Substances 0.000 claims abstract description 18
108090000765 processed proteins & peptides Proteins 0.000 claims description 77
238000006460 hydrolysis reaction Methods 0.000 claims description 62
102000004190 Enzymes Human genes 0.000 claims description 56
108090000790 Enzymes Proteins 0.000 claims description 56
230000007062 hydrolysis Effects 0.000 claims description 55
102000004196 processed proteins & peptides Human genes 0.000 claims description 50
230000000975 bioactive effect Effects 0.000 claims description 45
230000009849 deactivation Effects 0.000 claims description 17
230000036772 blood pressure Effects 0.000 claims description 16
108091005804 Peptidases Proteins 0.000 claims description 14
235000018102 proteins Nutrition 0.000 claims description 12
102000004169 proteins and genes Human genes 0.000 claims description 12
108090000623 proteins and genes Proteins 0.000 claims description 12
239000004365 Protease Substances 0.000 claims description 11
235000019419 proteases Nutrition 0.000 claims description 11
102000035195 Peptidases Human genes 0.000 claims description 9
239000002245 particle Substances 0.000 claims description 9
238000004519 manufacturing process Methods 0.000 claims description 8
239000012528 membrane Substances 0.000 claims description 7
239000003814 drug Substances 0.000 claims description 6
239000003937 drug carrier Substances 0.000 claims description 6
238000010438 heat treatment Methods 0.000 claims description 6
238000000108 ultra-filtration Methods 0.000 claims description 6
230000003301 hydrolyzing effect Effects 0.000 claims description 5
108010009355 microbial metalloproteinases Proteins 0.000 claims description 5
238000011282 treatment Methods 0.000 claims description 5
108091005658 Basic proteases Proteins 0.000 claims description 3
101001091385 Homo sapiens Kallikrein-6 Proteins 0.000 claims description 3
102100034866 Kallikrein-6 Human genes 0.000 claims description 3
108091005507 Neutral proteases Proteins 0.000 claims description 3
102000035092 Neutral proteases Human genes 0.000 claims description 3
101710180012 Protease 7 Proteins 0.000 claims description 3
-1 Validase Proteins 0.000 claims description 3
238000004925 denaturation Methods 0.000 claims description 3
230000036425 denaturation Effects 0.000 claims description 3
239000000463 material Substances 0.000 claims description 3
235000019833 protease Nutrition 0.000 claims description 3
108090000145 Bacillolysin Proteins 0.000 claims description 2
229920001661 Chitosan Polymers 0.000 claims description 2
230000004913 activation Effects 0.000 claims description 2
229920001525 carrageenan Polymers 0.000 claims description 2
235000010418 carrageenan Nutrition 0.000 claims description 2
229940113118 carrageenan Drugs 0.000 claims description 2
239000000679 carrageenan Substances 0.000 claims description 2
UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 2
102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims 5
230000002378 acidificating effect Effects 0.000 claims 1
239000000796 flavoring agent Substances 0.000 abstract description 13
235000019634 flavors Nutrition 0.000 abstract description 13
230000002401 inhibitory effect Effects 0.000 abstract description 5
229940088598 enzyme Drugs 0.000 description 45
239000000047 product Substances 0.000 description 38
235000019658 bitter taste Nutrition 0.000 description 22
230000000694 effects Effects 0.000 description 22
238000005187 foaming Methods 0.000 description 10
235000019640 taste Nutrition 0.000 description 10
102000014171 Milk Proteins Human genes 0.000 description 9
108010011756 Milk Proteins Proteins 0.000 description 9
235000021239 milk protein Nutrition 0.000 description 9
239000005862 Whey Substances 0.000 description 8
239000000243 solution Substances 0.000 description 8
241000700159 Rattus Species 0.000 description 7
230000037396 body weight Effects 0.000 description 7
241001465754 Metazoa Species 0.000 description 6
239000012141 concentrate Substances 0.000 description 6
230000006872 improvement Effects 0.000 description 6
239000007787 solid Substances 0.000 description 6
239000012467 final product Substances 0.000 description 5
238000000338 in vitro Methods 0.000 description 5
235000013336 milk Nutrition 0.000 description 5
239000008267 milk Substances 0.000 description 5
210000004080 milk Anatomy 0.000 description 5
239000000203 mixture Substances 0.000 description 5
230000007065 protein hydrolysis Effects 0.000 description 5
108010009736 Protein Hydrolysates Proteins 0.000 description 4
238000000855 fermentation Methods 0.000 description 4
230000004151 fermentation Effects 0.000 description 4
239000006041 probiotic Substances 0.000 description 4
230000000529 probiotic effect Effects 0.000 description 4
235000018291 probiotics Nutrition 0.000 description 4
102100030988 Angiotensin-converting enzyme Human genes 0.000 description 3
102000011632 Caseins Human genes 0.000 description 3
108010076119 Caseins Proteins 0.000 description 3
206010020772 Hypertension Diseases 0.000 description 3
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
230000001154 acute effect Effects 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
235000019606 astringent taste Nutrition 0.000 description 3
239000008280 blood Substances 0.000 description 3
210000004369 blood Anatomy 0.000 description 3
239000005018 casein Substances 0.000 description 3
BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 3
235000021240 caseins Nutrition 0.000 description 3
235000013351 cheese Nutrition 0.000 description 3
238000006243 chemical reaction Methods 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
235000009508 confectionery Nutrition 0.000 description 3
230000001631 hypertensive effect Effects 0.000 description 3
238000005342 ion exchange Methods 0.000 description 3
239000008101 lactose Substances 0.000 description 3
239000012466 permeate Substances 0.000 description 3
239000011541 reaction mixture Substances 0.000 description 3
230000009467 reduction Effects 0.000 description 3
230000001953 sensory effect Effects 0.000 description 3
230000002269 spontaneous effect Effects 0.000 description 3
230000035488 systolic blood pressure Effects 0.000 description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
235000013618 yogurt Nutrition 0.000 description 3
108091005508 Acid proteases Proteins 0.000 description 2
102100026189 Beta-galactosidase Human genes 0.000 description 2
101000993347 Gallus gallus Ciliary neurotrophic factor Proteins 0.000 description 2
102000010445 Lactoferrin Human genes 0.000 description 2
108010063045 Lactoferrin Proteins 0.000 description 2
230000001133 acceleration Effects 0.000 description 2
108010005774 beta-Galactosidase Proteins 0.000 description 2
230000015572 biosynthetic process Effects 0.000 description 2
238000005119 centrifugation Methods 0.000 description 2
238000001816 cooling Methods 0.000 description 2
235000013365 dairy product Nutrition 0.000 description 2
235000021185 dessert Nutrition 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000002255 enzymatic effect Effects 0.000 description 2
235000012041 food component Nutrition 0.000 description 2
239000005417 food ingredient Substances 0.000 description 2
230000002209 hydrophobic effect Effects 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000004044 response Effects 0.000 description 2
239000000126 substance Substances 0.000 description 2
235000000346 sugar Nutrition 0.000 description 2
150000008163 sugars Chemical class 0.000 description 2
239000006228 supernatant Substances 0.000 description 2
235000019605 sweet taste sensations Nutrition 0.000 description 2
AOKLUWFWNZLQSN-LROMGURASA-N (2s)-2-[[(2s)-2-[[(2s)-2-[[(2s)-2-acetamido-6-aminohexanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-n-[(2s)-1-amino-4-methyl-1-oxopentan-2-yl]butanediamide Chemical compound NCCCC[C@H](NC(C)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@H](C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(N)=O)CC1=CC=C(O)C=C1 AOKLUWFWNZLQSN-LROMGURASA-N 0.000 description 1
ZDLZKMDMBBMJLI-FDMDGMSGSA-N 2-[[2-[[(2s)-2-[[(e)-3-(furan-2-yl)prop-2-enoyl]amino]-3-phenylpropanoyl]amino]acetyl]amino]acetic acid Chemical compound C([C@@H](C(=O)NCC(=O)NCC(=O)O)NC(=O)\C=C\C=1OC=CC=1)C1=CC=CC=C1 ZDLZKMDMBBMJLI-FDMDGMSGSA-N 0.000 description 1
108010048632 2-furanacryloyl-phenylalanyl-glycyl-glycine Proteins 0.000 description 1
239000005541 ACE inhibitor Substances 0.000 description 1
240000006439 Aspergillus oryzae Species 0.000 description 1
235000002247 Aspergillus oryzae Nutrition 0.000 description 1
206010012735 Diarrhoea Diseases 0.000 description 1
208000001860 Eye Infections Diseases 0.000 description 1
239000005905 Hydrolysed protein Substances 0.000 description 1
108010059881 Lactase Proteins 0.000 description 1
241000254697 Lactobacillus rhamnosus HN001 Species 0.000 description 1
108010006701 N-acetyllysyl-arginyl-tyrosyl-asparaginyl-leucinamide Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
241000031670 Saccharopolyspora thermophila Species 0.000 description 1
238000012300 Sequence Analysis Methods 0.000 description 1
238000010793 Steam injection (oil industry) Methods 0.000 description 1
239000002253 acid Substances 0.000 description 1
238000005377 adsorption chromatography Methods 0.000 description 1
230000002009 allergenic effect Effects 0.000 description 1
125000003275 alpha amino acid group Chemical group 0.000 description 1
229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
230000003276 anti-hypertensive effect Effects 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
238000013459 approach Methods 0.000 description 1
230000008901 benefit Effects 0.000 description 1
230000004071 biological effect Effects 0.000 description 1
235000019636 bitter flavor Nutrition 0.000 description 1
238000009530 blood pressure measurement Methods 0.000 description 1
229940021722 caseins Drugs 0.000 description 1
239000007795 chemical reaction product Substances 0.000 description 1
239000013065 commercial product Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000004132 cross linking Methods 0.000 description 1
238000011161 development Methods 0.000 description 1
235000021245 dietary protein Nutrition 0.000 description 1
208000010643 digestive system disease Diseases 0.000 description 1
229940079593 drug Drugs 0.000 description 1
238000001035 drying Methods 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
208000011323 eye infectious disease Diseases 0.000 description 1
230000002349 favourable effect Effects 0.000 description 1
230000005714 functional activity Effects 0.000 description 1
235000013376 functional food Nutrition 0.000 description 1
230000036541 health Effects 0.000 description 1
239000012510 hollow fiber Substances 0.000 description 1
239000000413 hydrolysate Substances 0.000 description 1
238000004191 hydrophobic interaction chromatography Methods 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
238000010348 incorporation Methods 0.000 description 1
239000002198 insoluble material Substances 0.000 description 1
238000002955 isolation Methods 0.000 description 1
CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 description 1
229940116108 lactase Drugs 0.000 description 1
235000021242 lactoferrin Nutrition 0.000 description 1
229940078795 lactoferrin Drugs 0.000 description 1
238000004949 mass spectrometry Methods 0.000 description 1
208000004396 mastitis Diseases 0.000 description 1
238000005374 membrane filtration Methods 0.000 description 1
244000005700 microbiome Species 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
235000016709 nutrition Nutrition 0.000 description 1
230000035764 nutrition Effects 0.000 description 1
210000003254 palate Anatomy 0.000 description 1
230000036961 partial effect Effects 0.000 description 1
ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical class O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 1
230000001766 physiological effect Effects 0.000 description 1
229920001184 polypeptide Polymers 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
230000002829 reductive effect Effects 0.000 description 1
238000001223 reverse osmosis Methods 0.000 description 1
238000004007 reversed phase HPLC Methods 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
235000020161 semi-skimmed milk Nutrition 0.000 description 1
235000021262 sour milk Nutrition 0.000 description 1
238000011699 spontaneously hypertensive rat Methods 0.000 description 1
238000010561 standard procedure Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
BWMISRWJRUSYEX-SZKNIZGXSA-N terbinafine hydrochloride Chemical compound Cl.C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 BWMISRWJRUSYEX-SZKNIZGXSA-N 0.000 description 1
238000012360 testing method Methods 0.000 description 1
201000004647 tinea pedis Diseases 0.000 description 1
230000000007 visual effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Immunology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Polymers & Plastics (AREA)
Nutrition Science (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Food Science & Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Genetics & Genomics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Mycology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Dairy Products (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

NO20031096A 2000-09-11 2003-03-10 Myseprotein-hydrolysat, fremgangsmate for dets fremstilling, farmasoytisk sammensetning, matprodukt samt anvendelse. NO326072B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
NZ506866A NZ506866A (en)	2000-09-11	2000-09-11	Bioactive whey protein hydrolysate free of bitter flavours wherein the enzyme used is a heat labile protease
PCT/NZ2001/000188 WO2002019837A1 (en)	2000-09-11	2001-09-11	Improved bioactive whey protein hydrolysate

Publications (3)

Publication Number	Publication Date
NO20031096D0 NO20031096D0 (no)	2003-03-10
NO20031096L NO20031096L (no)	2003-05-07
NO326072B1 true NO326072B1 (no)	2008-09-15

Family

ID=19928101

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031096A NO326072B1 (no)	2000-09-11	2003-03-10	Myseprotein-hydrolysat, fremgangsmate for dets fremstilling, farmasoytisk sammensetning, matprodukt samt anvendelse.

Country Status (19)

Country	Link
EP (1)	EP1317186B1 (ja)
JP (1)	JP2004508025A (ja)
KR (1)	KR100845362B1 (ja)
CN (1)	CN1229031C (ja)
AT (1)	ATE494795T1 (ja)
AU (2)	AU9037601A (ja)
BR (1)	BR0113812A (ja)
CA (1)	CA2421714A1 (ja)
DE (1)	DE60143846D1 (ja)
DK (1)	DK1317186T3 (ja)
ES (1)	ES2359789T3 (ja)
HK (1)	HK1063132A1 (ja)
HU (1)	HUP0302370A2 (ja)
MX (1)	MXPA03002109A (ja)
NO (1)	NO326072B1 (ja)
NZ (1)	NZ506866A (ja)
PE (1)	PE20030289A1 (ja)
WO (1)	WO2002019837A1 (ja)
ZA (1)	ZA200301982B (ja)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK1545235T3 (da)	2002-07-29	2014-01-27	Zymtech Production As	Fremgangsmåde til fremstilling af peptider og aminosyrer fra proteinholdigt materiale af animalsk oprindelse
TWI317636B (en) *	2002-11-22	2009-12-01	Meiji Dairies Corp	Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
US7399496B2 (en)	2003-02-07	2008-07-15	Glanbia Nutritionals (Ireland) Limited	Hydrolyzed whey protein compositions
EP1568707A1 (en) *	2004-02-26	2005-08-31	Puleva Biotech, S.A.	Antihypertensive peptides from casein hydrolysates
CN100415768C (zh) *	2004-11-29	2008-09-03	中国农业大学	乳清蛋白酶法生产血管紧张素转化酶（ace）抑制肽的方法
US20100056458A1 (en) *	2005-06-30	2010-03-04	Campina Nederland Holding B.V.	Peptides Inhibiting Angiotensin-Converting Enzyme
BRPI0707045A2 (pt) *	2006-03-24	2011-04-12	Unilever Nv	produto alimentìcio e uso de um produto alimentìcio
JP5306188B2 (ja) *	2006-06-15	2013-10-02	マレー・ゴールバーン・コー−オペラティヴ・カンパニー・リミテッド	筋肉回復を高めるための乳清タンパク質および加水分解物を含む調製物
EP1967524A1 (en) *	2007-03-06	2008-09-10	Friesland Brands B.V.	Methods for producing ACE-inhibitory peptides from whey and peptides obtained thereby
WO2009097541A1 (en) *	2008-02-01	2009-08-06	Rich Products Corporation	Foam compositions
DE102008032828A1 (de) *	2008-07-02	2010-01-07	Technische Universität Dresden	Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel
US9055752B2 (en)	2008-11-06	2015-06-16	Intercontinental Great Brands Llc	Shelf-stable concentrated dairy liquids and methods of forming thereof
CN101736067B (zh) *	2010-01-08	2012-04-18	中国农业大学	一种乳清蛋白降血压肽及其制备方法与应用
CN101829316B (zh) *	2010-04-30	2012-07-11	中国人民解放军总医院	一种乳清蛋白水解物及其在制备降糖药物中的用途
UA112972C2 (uk)	2010-09-08	2016-11-25	Інтерконтінентал Грейт Брендс ЛЛС	Рідкий молочний концентрат з високим вмістом сухих речовин
US20140011742A1 (en) *	2010-12-09	2014-01-09	Mcgill University	Bioactive Peptides and Proteins Containing Bioactive Peptides, their Uses and Processes for Making the Same
JP5892687B2 (ja) *	2011-07-07	2016-03-23	高砂香料工業株式会社	風味改善ペプチド
CN103695518B (zh) *	2013-12-30	2016-04-06	东北农业大学	利用乳清蛋白肽降低血清胆固醇水平的产品和制备方法
US10639334B2 (en) *	2014-01-07	2020-05-05	Mead Johnson Nutrition Company	Pediatric nutritional composition with milk peptides for healthy growth and development
CN103805664B (zh) *	2014-03-06	2017-04-05	渤海大学	一种低敏性糖基化乳清蛋白水解物及其制备方法
WO2015169928A1 (en) *	2014-05-07	2015-11-12	Nestec S.A.	Foamable dairy product
BR112016027871A2 (pt) *	2014-06-16	2017-10-24	Kirin Kk	composição para melhorar a memória, a função de aprendizado e/ou função cognitiva
JP6262694B2 (ja) *	2014-08-18	2018-01-17	森永乳業株式会社	プロリルオリゴペプチダーゼ阻害剤
WO2016174651A2 (en)	2015-10-01	2016-11-03	Frieslandcampina Nederland B.V.	Liquid nutritional composition comprising micellar casein and hydrolysed whey protein
JPWO2017086303A1 (ja) *	2015-11-16	2018-09-20	キリン株式会社	ペプチド組成物およびその製造方法
WO2017102258A1 (en)	2015-12-18	2017-06-22	Nestec S.A.	Heat sterilized high protein compositions with hydrolyzed protein from a continuous process with at least one endopeptidase
CN107136295B (zh) *	2016-03-01	2021-07-27	内蒙古伊利实业集团股份有限公司	一种部分水解乳清蛋白粉及其制备方法
CN107814836A (zh) *	2017-12-01	2018-03-20	浙江熊猫乳业集团股份有限公司	一种生物活性多肽fpgpipns及其制备方法和应用
CN107858394B (zh) *	2017-12-25	2021-09-07	内蒙古蒙牛乳业（集团）股份有限公司	乳清蛋白水解产物的制备方法
BR112021023681A2 (pt)	2019-05-29	2022-01-04	Arla Foods Amba	Hidrolisados de proteína de soro de leite extensamente hidrolisada palatável
CN113061175B (zh) *	2020-12-17	2023-04-21	西北民族大学	以曲拉为原料制备的钙共沉淀蛋白及其制备方法
CN114457137B (zh) *	2022-01-12	2024-05-24	广州舜康生物科技有限公司	一种连续循环水解并精准筛选肽分子量的深度水解乳清蛋白的制备方法
CN115669945B (zh) *	2022-10-24	2024-03-08	上海艾斯顿医疗科技有限公司	一种具有神经营养作用的脂质体包裹多肽及制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK589785A (da) *	1985-12-18	1987-06-19	Samuelsson Ernst Gunnar	Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
SE459140B (sv) *	1986-11-25	1989-06-12	Albuglobe Ab	Hydrolys av vassleprotein foer att underlaetta avskiljning av fett daerifraan
EP0518999B1 (en) *	1990-03-09	1995-08-30	Novo Nordisk A/S	Protein hydrolysates
AU656977B2 (en) *	1991-05-31	1995-02-23	Danmark Protein A/S	Method for production of a whey protein hydrolyzate
AU2468292A (en) *	1991-08-30	1993-04-05	Teagasc, The Agriculture And Food Development Authority	Hypoallergenic whey protein hydrolysate
DK71292D0 (ja) *	1992-05-27	1992-05-27	Novo Nordisk As
JP3059595B2 (ja) *	1992-11-20	2000-07-04	森永乳業株式会社	沈澱を生じない乳清蛋白質分解物の製造法
EP0799577B1 (en) *	1994-10-14	2001-02-14	Morinaga Milk Industry Co., Ltd.	Peptide mixture and products thereof
WO1997001966A1 (en) *	1995-06-30	1997-01-23	Md Foods Amba	A method of producing a peptide mixture
JPH1033115A (ja) *	1996-07-24	1998-02-10	Nouchikusangiyou Shinko Jigyodan	ホエー飲料とその製造法
WO1999065326A1 (en) *	1998-06-17	1999-12-23	New Zealand Dairy Board	Bioactive whey protein hydrolysate
MY129566A (en) *	1999-01-19	2007-04-30	Nestle Sa	A hypoallergenic composition containing tolerogenic peptides inducing oral tolerance

2000
- 2000-09-11 NZ NZ506866A patent/NZ506866A/en unknown
2001
- 2001-09-11 DE DE60143846T patent/DE60143846D1/de not_active Expired - Lifetime
- 2001-09-11 AU AU9037601A patent/AU9037601A/xx active Pending
- 2001-09-11 AT AT01970375T patent/ATE494795T1/de not_active IP Right Cessation
- 2001-09-11 EP EP01970375A patent/EP1317186B1/en not_active Expired - Lifetime
- 2001-09-11 HU HU0302370A patent/HUP0302370A2/hu unknown
- 2001-09-11 CA CA002421714A patent/CA2421714A1/en not_active Abandoned
- 2001-09-11 AU AU2001290376A patent/AU2001290376B2/en not_active Ceased
- 2001-09-11 ES ES01970375T patent/ES2359789T3/es not_active Expired - Lifetime
- 2001-09-11 DK DK01970375.0T patent/DK1317186T3/da active
- 2001-09-11 BR BR0113812-0A patent/BR0113812A/pt not_active IP Right Cessation
- 2001-09-11 CN CNB018187250A patent/CN1229031C/zh not_active Expired - Fee Related
- 2001-09-11 KR KR1020037003596A patent/KR100845362B1/ko not_active IP Right Cessation
- 2001-09-11 JP JP2002524329A patent/JP2004508025A/ja active Pending
- 2001-09-11 MX MXPA03002109A patent/MXPA03002109A/es not_active Application Discontinuation
- 2001-09-11 WO PCT/NZ2001/000188 patent/WO2002019837A1/en active IP Right Grant
- 2001-09-20 PE PE2001000942A patent/PE20030289A1/es not_active Application Discontinuation
2003
- 2003-03-10 NO NO20031096A patent/NO326072B1/no not_active IP Right Cessation
- 2003-03-11 ZA ZA200301982A patent/ZA200301982B/en unknown
2004
- 2004-08-09 HK HK04105950A patent/HK1063132A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
CA2421714A1 (en)	2002-03-14
EP1317186A1 (en)	2003-06-11
EP1317186A4 (en)	2006-04-19
KR20030046442A (ko)	2003-06-12
ZA200301982B (en)	2004-06-25
HUP0302370A2 (hu)	2003-10-28
MXPA03002109A (es)	2004-05-24
KR100845362B1 (ko)	2008-07-09
DE60143846D1 (de)	2011-02-24
WO2002019837A1 (en)	2002-03-14
NO20031096L (no)	2003-05-07
PE20030289A1 (es)	2003-03-25
CN1229031C (zh)	2005-11-30
DK1317186T3 (da)	2011-05-02
AU9037601A (en)	2002-03-22
HK1063132A1 (en)	2004-12-17
NZ506866A (en)	2003-05-30
CN1474656A (zh)	2004-02-11
EP1317186B1 (en)	2011-01-12
ES2359789T3 (es)	2011-05-26
ATE494795T1 (de)	2011-01-15
JP2004508025A (ja)	2004-03-18
BR0113812A (pt)	2005-02-01
AU2001290376B2 (en)	2005-08-25
NO20031096D0 (no)	2003-03-10

Legal Events

Date	Code	Title	Description
2011-05-09	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
US7148034B2 (en)	2006-12-12	Bioactive whey protein hydrolysate
NO326072B1 (no)	2008-09-15	Myseprotein-hydrolysat, fremgangsmate for dets fremstilling, farmasoytisk sammensetning, matprodukt samt anvendelse.
AU2001290376A1 (en)	2002-06-13	Improved bioactive whey protein hydrolysate
CA2452765C (en)	2010-09-28	Process for the hydrolysis of milk proteins
EP0226221B1 (en)	1991-07-03	A peptide preparation, a process for producing it and use of the peptide preparation
AU2002325890A1 (en)	2003-05-22	Process for the hydrolysis of milk proteins
JP7252733B2 (ja)	2023-04-05	乳蛋白質加水分解物の製造方法
AU2003204321B2 (en)	2006-02-09	Bioactive Whey Protein Hydrolysate
JPH0678685A (ja)	1994-03-22	不快味のない蛋白質加水分解物の製造法
JPH0254061B2 (ja)	1990-11-20
JP2003339326A (ja)	2003-12-02	乳清蛋白質加水分解物及びその製造方法